dcc-3116,Trametinib,Binimetinib,Sotorasib
deciphera,novartis,ono Pharmaceuticalscueticals,pierre fabre,pfizer,amgen
['dcc-3116', 'solid tumor', 'dcc-3116 ']
dcc-3116 demonstrated safety and tolerability across various dose levels in patients with solid tumors harboring a ras or raf mutation, according to findings from a phase 1/2 trial presented at #esmo2022. | 
Oncology news and insights from leading researchers and cancer centers.